FDA Inspection
Park Avenue CompoundingPark Avenue Compounding – FDA Inspection, Aug 28, 2019
Record Details
This FDA Inspection record concerns Park Avenue Compounding, with an inspection on August 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d5ad6aa9-c8ee-478a-a078-e2b5877ef49b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1100607
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.46(a)Adequate ventilation not provided
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.160(b)(1)Sampling and testing procedures described
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Park Avenue Compounding
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| February 8, 2024 | OAI | Drug Quality Assurance | |
| November 16, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Park Avenue Compounding
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.